Ex-Lehman bankers reunite at cancer specialist

Aim-listed Advanced Oncotherapy recruits former Lehman Brothers and Lazard banker as global head of finance

Advanced Oncotherapy, an Aim-listed healthcare company developing new therapies for treating cancer, has recruited a former Lehman Brothers banker – reuniting him with a former colleague at the US bank.

The company has appointed Nicolas Serandour as global head of finance, effective September 1, according to a statement this morning. The company, which has a market capitalisation of around £32 million, is developing particle treatment that is less toxic for cancer patients than conventional X-ray radiation.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump